Tailoring Smoking Cessation Treatment by Genotype:
Implications for Ethics and Clinical Practice (RWJ TTURC)

Dr. Shields is currently a PI for a 5-year grant from the Robert Wood Johnson Foundation to study clinical and ethical issues related to tailoring smoking cessation treatment by genotype.